Archive for the ‘Benzinga’ Category

Carl Icahn’s Track Record In Big Pharma

Courtesy of Benzinga.

Carl Icahn's Track Record In Big Pharma

Billionaire investor and corporate raider Carl Icahn has trained his eyes on Bristol-Myers Squibb Co (NYSE: BMY). A Wall Street Journal report revealed on Tuesday that Icahn has picked up a substantial stake in the pharma giant, although the report did not put a number to it.

Does Icahn’s interest mean the company is in for a radical overhaul? The report also suggested that Icahn is impressed with the company’s experimental drug pipeline even as he thinks it is an acquisition target.

Since August last year, shares of Bristol-Myers have been languishing, as they are down over 13 percent. The company’s cancer immunotherapy franchise Opdivo has not done well as it should have, consequently ceding share to rivals.

Related Link: Which Pharma Players Dominate The Lung Cancer Space?

BMY Chart

Source: Y Charts

Now, how would Icahn’s association impact Bristol-Myers Squibb? Will he be content merely with getting board representation? The Street is awash with speculation that Icahn could force the company to put itself on the block. A logical call, given that the decline in stock price over the past year on the failed Opdivo trial has left the company thin on valuation.

The development has come at a time when the Trump administration is expected to overhaul the corporate tax code, including allowing a tax holiday to influence companies to repatriate profits stashed overseas. This could free up resources for a potential acquirer to make a bid for Bristol-Myers Squibb.

The names doing the round include Pfizer Inc. (NYSE: PFE), Roche Holding Ltd. (ADR) (OTC: RHHBY) and Novartis AG (ADR) (NYSE: NVS).…
continue reading

GEO Group: Sally Yates’ Decision To Stop Private Prison Use Was Based On A ‘Misrepresentation’

Courtesy of Benzinga.

GEO Group: Sally Yates' Decision To Stop Private Prison Use Was Based On A 'Misrepresentation'

Shares of private prison operators The GEO Group Inc (NYSE: GEO) and Corecivic Inc (NYSE: CXW) continued their rally after Attorney General Jeff Sessions reversed the Obama-era Department of Justice efforts to reduce use of private prisons.

Private Prisons And Politics

“We believe that the decision made last August [by Deputy Attorney General Sally Yates] was based on a misrepresentation of the report issued by the Department of Justice, Office of Inspector General,” Pablo Paez, GEO Group’s vice president, corporate relations, told Benzinga.

Paez pointed to the OIG report that showed that privately prisons are at least as equally safe, secure and humane as publicly run facilities, and often more so.

Related Link: Homeland Security Reportedly Needs More Beds For Immigrant Detainees In Big Windfall For Private Prisons

The Case For Privately Operated Facilities

Furthermore, the executive said the OIG found that privately operated facilities experienced lower rates of inmate deaths, lower rates of guilty findings of inmate on inmate sexual assault, lower rates of allegations of staff against inmate sexual assault, lower rates of positive drug tests, and lower rates of inmate grievances.

The Experts Weigh In

In a note earlier this week, Deutsche Bank analysts said they believe the Trump administration’s focus on immigration would benefit the private prison industry. The brokerage prefers CoreCivic Over GEO Group is due to the higher exposure of the former (28 percent compared to 23 percent for the latter) to ICE.

Shares of CoreCivic closed Thursday’s trading at $34 and GEO at $47.37. In the pre-market hours Friday, CoreCivic shares were up 1.35 percent to $34.46 and GEO gained 1.90 percent to $48.27.

Latest Ratings for CXW

Date Firm Action From To
Feb 2017 Deutsche Bank Initiates Coverage On Buy
Dec 2016 Canaccord Genuity Upgrades Hold Buy
Nov 2016 Canaccord Genuity Maintains Hold

View More Analyst Ratings for CXW

View the Latest Analyst Ratings

Posted-In: Barack ObamaAnalyst Color News Politics Analyst Ratings Movers Interview General Best of Benzinga

Wal-Mart Should Follow Home Depot’s Example To Improve Return On Capital

Courtesy of Benzinga.

A positive comp sales and traffic during the Holiday quarter and a surge in online orders isn’t enough for Argus to become more constructive on Wal-Mart Stores Inc (NYSE: WMT) shares. Argus still rates Wal-Mart Hold as it wants the company to improve its return on investment.

In the fourth quarter, Wal-Mart’s trailing 12-month ROI declined by 30 basis points to 15.2 percent. Adjusted operating income fell 1.7 percent, while average invested capital increased 0.7 percent.

“We believe that Wal-Mart must significantly improve its return on invested capital to become a multiyear outperformer,” analyst Christopher Graja wrote in a note.

In fact, Graja wants Wal-Mart to take a leaf out of Home Depot Inc (NYSE: HD)’s book to improve return on invested capital (ROIC).

According to Bloomberg data, Wal-Mart ended FY11 with an ROIC of 14.6 percent and FY2017 with an ROIC of 12.2 percent. By contrast, Home Depot ended FY2011 with an ROIC of 12.8 percent — about 180 basis points lower than Wal-Mart – but ended FY2017 with an ROIC of 30.3 percent, more than twice as high as the retail giant.

Graja noted Wal-Mart should grow income faster than sales and sales faster than its capital base.

“The implication is that it is not enough to simply boost earnings by opening more mildly profitable stores or to boost comp sales by stuffing stores with more inventory,” Graja highlighted.

Related Link: Wal-Mart CEO Issues 3 Predictions For The Future Of Retail

Since the end of FY2011, Wal-Mart has increased square footage by 18 percent. But, Bloomberg data shows that sales have declined during this period to $420 per square foot from $436, and EBIT has dropped to $20 per square foot from $26.

On the other hand, Home Depot raised its square footage by less than 1 percent over the same period. But, the home improvement retailer’s sales have increased to almost $400 per square foot from $289, and EBIT has…
continue reading

Ambarella’s Hyper-Seasonality Continues To Be A Concern

Courtesy of Benzinga.

Ambarella's Hyper-Seasonality Continues To Be A Concern

Previewing Ambarella Inc (NASDAQ: AMBA)’s fourth-quarter results, Deutsche Bank said in a note released on Thursday the hyper-seasonality of the company’s demand patterns continues to leave it on the sidelines. That said, the firm is impressed with the company’s continued advances in technology and end-market applications.

Q4 Headline Numbers To Align With Street

Analysts Ross Seymore and Sidney Ho expects a likely in-line print for the fourth quarter as GoPro Inc (NASDAQ: GPRO) appears back on track. The analysts expect Ambarella’s fourth-quarter revenues to be at $87 million, above the $86 million Street view, with the upside attributed to better than expected growth in sports/wearables. The segment is expected to report a 20 percent sequential drop. Earnings per share are likely to match the Street estimate of $0.75, the analysts added.

Related Link: Ambarella Slowly Emerging From GoPro’s Shadow

Expected Q4 Performance By Other Segments

  • IP Security: Down 8 percent sequentially.
  • Drones: Down 15 percent sequentially on seasonal build patterns.
  • Auto: 10 percent sequential drop.

Above-Consensus Q1 Guidance Likely

Deutsche Bank expects Ambarella to guide first-quarter revenues to $76 million, above the $71 million consensus estimate, and earnings per share to $0.58 versus the $0.48 Street estimate. Segment-wise break-up of expectations concerning the first quarter guidance are as follows:

  • IP Security: Down 8 percent sequentially.
  • Auto: Down 5 percent sequentially.
  • Drones: Flat.
  • Sports & Wearables: Down 25 percent sequentially, incorporating a conservative potential first half inventory burn estimate.

The company is scheduled to release its results after the market close Feb. 28.

Deutsche Bank maintains its Hold rating and $65 price target for the shares of the company.

At the time of writing, Ambarella was surging up 3.17 percent to $58.84.

Latest Ratings for AMBA

Date Firm Action From To
Nov 2016 KeyBanc Maintains Overweight
Sep 2016 Roth Capital Initiates Coverage on Buy
Aug 2016 KeyBanc Maintains Overweight

View More Analyst Ratings for AMBA

View the Latest Analyst Ratings

Posted-In: Analyst Color Earnings News Guidance Previews Reiteration Analyst Ratings Movers Best of Benzinga

Tesla: Bear Vs. Bull Case Rests On Model 3, Capital Structure

Courtesy of Benzinga.

Tesla: Bear Vs. Bull Case Rests On Model 3, Capital Structure

Tesla Inc (NASDAQ: TSLA) shares are down over five percent following the company’s fourth-quarter earnings after the close on Wednesday. The company beat sales estimates on its latest report, despite burning a record $1 billion in cash flow in the quarter.

With Tesla moving aggressively towards its Model 3 production ramp, set to launch in July, analysts believe the company will look to raise capital to avoid hindering production on the highly anticipated launch. Tesla is expected to spend $2 billion–$2.5 billion in capex in the first half of 2017.

Analyst Commentary

“We agree and believe clarity on the company’s capital plan and completion of a capital raise would be a positive catalyst for shares” said Oppenheimer on Wednesday. “We believe guidance for 250,000 annual production runrate by 4Q17 is ahead of Street expectations and comes with significant execution risk. As the company works towards lofty manufacturing efficiency goals in scaling to 1 million annual vehicle production targets, we expect bears to focus on earnings power of the business by 2020.”

Related Link: Why One Analyst Is Gaining Confidence In Tesla’s Potential For Profitability

Oppenheimer remains on the sidelines given the production execution risks that persist, while it waits for more clarity on Tesla’s capital structure. On the earnings call, it was announced that Tesla Chief Financial Officer Jason Wheeler was leaving the company to enter the public sector, and Deepak Ahuja will return to the position, one he held from 2008 to 2015.

Bull Case:

  • Gigafactory continues to ramp ahead of expectations.
  • Tesla begins to reveal ways to monetize its network beyond hardware sales.
  • Model 3 production ramps on schedule.

Bear Case:

  • Model 3 production is delayed into second-half 2018.
  • Gigafactory ramp is delayed.
  • Capex exceeds investor expectations.

Oppenheimer maintains a Perform rating on Tesla and sees FY 2017 revenue of $10.13…
continue reading

22 Biggest Mid-Day Losers For Thursday

Courtesy of Benzinga.

  • Ocean Rig UDW Inc. (NASDAQ: ORIG) shares dipped 25.6 percent to $0.803 Ocean Rig UDW reported a Q4 loss of $3.71 billion on revenue of $355.4 million.
  • Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) shares fell 22.6 percent to $4.19. Cyclacel reported that its Phase 3 SEAMLESS study did not meet primary endpoint.
  • DryShips Inc. (NASDAQ: DRYS) shares dropped 19.3 percent to $2.18. DryShips shares have dropped 99.80 percent over the past 52 weeks, while the S&P 500 index has gained 22.98 percent in the same period.
  • Atlantic Alliance Partnership Corp (NASDAQ: AAPC) shares declined 17.7 percent to $11.92. Atlantic Alliance Partnership shares have surged 41.64 percent over the past 52 weeks, while the S&P 500 index has gained 22.98 percent in the same period.
  • Ocwen Financial Corp (NYSE: OCN) dropped 17.6 percent to $ 4.45. Ocwen Financial reported a Q4 loss of $0.08 per share on revenue of $323.9 million.
  • L Brands Inc (NYSE: LB) dipped 16.9 percent to $48.33. L Brands reported upbeat earnings for its fourth quarter, but issued disappointing outlook for 2017.
  • InterDigital, Inc. (NASDAQ: IDCC) shares declined 16 percent to $85.00 after the company issued a weak forecast for the current quarter.
  • ARRIS International plc (NASDAQ: ARRS) dropped 15 percent to $26.10. ARRIS issued a weak forecast for the first quarter and announced plans to acquire Ruckus Wireless and ICX Switch business for $800 million in cash.
  • Genesis Healthcare Inc (NYSE: GEN) shares declined 13.8 percent to $3.30 on Q4 results.
  • Weibo

continue reading

AirBnB Vs. Accor: The Battle For Luxury Rental Market Supremacy

Courtesy of Benzinga.

AirBnB Vs. Accor: The Battle For Luxury Rental Market Supremacy

Hospitality giants are showing increased interest in the luxury vacation rental sector.

It is no mystery that AirBnB and Accor SA are growing at an astonishing pace. That’s because both companies are constantly on the lookout for expansion opportunities. Recently, the luxury vacation rental sector has attracted their attention, leading to two game-changing acquisitions.


Motivation for AirBnB’s $300 million acquisition of Luxury Retreats, a Montreal-based high-end vacation rental company is clear; AirBnB is looking for opportunities to scale. This includes broadening its target market to include higher-paying clientele.

The company does so with the hope that customers willing to pay top dollar for glossy villas will also be willing to pay for AirBnB’s luxury tourism service — from private guided tours to truffle tastings.

Additionally, according to a Bloomberg report, the rental giant is also looking to expand into a full-service travel company thanks to over $3 billion in venture capital funding, by offering things like airfare aggregation and itinerary planning.

Although Luxury Retreats uses a slightly different pay structure, by charging a 20 percent commission on rental fees, revenue will closely match AirBnB’s current, cumulative model that combines listing and booking fees. Lending weight to optimism regarding the company’s profitability in 2017.


AccorHotels has also jumped on the luxury vacation rental bandwagon. The Paris-based multinational hospitality giant, which owns and operates a variety of hotel franchises, is currently negotiating the acquisition of Travel Keys. Accor’s CEO, Sébastian Bazin, is transparent about his reasons for pursuing the luxury rental company. Like AirBnB, Accor’s objective is also related to scalability — to ultimately become “the number one luxury private rental player in the world.”

Bazin’s goal seems reasonable, given the enthusiasm with which Bobby Gibson, CEO of Travel Keys, brings to the acquisition. He shares “the vision of both Sebastien Bazin and the private rental leaders at AccorHotels about the future of our industry.” With Travel Keys bringing over 5,000 properties and top-notch attention to hosts and guests, this certainly seems like a promising symbiosis.

Looking Ahead: Possible Buyers And Sellers

These two impending acquisitions foreshadow a pattern in the vacation rental property industry, making many investors and economists ask “who’s next?” The key for potential…
continue reading

Square Finishes 2016 On A Strong Note, Remains A Key Idea In The New Year

Courtesy of Benzinga.

Square Finishes 2016 On A Strong Note, Remains A Key Idea In The New Year

Square Inc (NYSE: SQ) reported a strong fourth-quarter beat and raised its guidance. Adjacent products contributed ~5 percent of payment volume, while “loan growth and food delivery also topped our expectations, offering early proof of the platform potential,” Pacific Crest’s Josh Beck said in a report.

Beck maintains an Overweight rating on the company, while raising the price target from $17 to $18.

Q4 Results

Square reported payment volume growth of 34 percent and Square Capital origination of $248 million, representing 68 percent year-over-year growth. Subscription and services based revenue came in at $40.5 million, higher than Pacific Crest’s estimate of $37.9 million.

The company announced adjusted revenue of $191.8 million, ahead of the consensus expectation of $187.7 million. Adjusted EBITDA came in at $29.8 million, significantly ahead of the Street’s estimate of $18 million, backed by lower operating expenses.

Related Link: Steve Ballmer’s Quick Advice To Dorsey: Quit Square

Key Idea For 2017

The Q4 results highlighted the company’s emerging platform potential, Beck commented. He added, “Square has a rich ecosystem of transaction, SKU-level, customer and inventory data that could enable it to extend beyond payments and play a larger role in commerce, which positively ties to one of our key secular FinTech themes.”

The analyst expressed optimism regarding the “Square for retail” opportunity and termed it as an “underappreciated upside driver.”

At last check, shares of Square were up 12.03 percent at $16.85.

Image Credit: By Mybloodtypeiscoffee (Own work) [CC BY 4.0], via Wikimedia Commons

Latest Ratings for SQ

Date Firm Action From To
Feb 2017 BTIG Research Upgrades Neutral Buy
Feb 2017 Citigroup Initiates Coverage On Buy
Dec 2016 Nomura Initiates Coverage On Buy

View More Analyst Ratings for SQ

View the Latest Analyst Ratings

Posted-In: Analyst Color Fintech Long Ideas News Price Target Reiteration Analyst Ratings Movers Best of Benzinga

Bristol-Myers Oncology Growth Potential Remains High

Courtesy of Benzinga.

Bristol-Myers Oncology Growth Potential Remains High

Bristol-Myers Squibb Co (NYSE: BMY) “has named three independent directors to its board amid reports that JANA Partners and Carl Icahn have taken stakes in BMY,” said Argus’ David Toung in a note, while reiterating a Buy rating on the company, with a price target of $75.

Board Changes

The analyst mentioned that Bristol Myers Squibb has also raised speculation that the company would be more open to increasing shareholder value with the addition of three independent board members, following discussions with activist investor, JANA Partners.

JANA Partners had disclosed in a filing in mid-February that it owned Bristol-Myers Squibb stock worth $226 million, representing 0.2 percent interest.

“Bristol-Myers has also attracted interest from Carl Icahn, according to reports in Bloomberg and other news outlets, who took a stake in BMY after the announcement of the new board appointments and a $2 billion accelerated stock repurchase program,” Toung stated.

The size of Icahn’s stake in the company is as yet undisclosed.

Related Link: Wall Street’s M&A Chatter From February 21

Oncology Drug

The analyst expects the company’s oncology drug, Opdivo, to face heightened competition in 2017, although the drug is also expected to gain additional approvals over the next 22 months, adding to its 10 indications at present.

“BMY also expects data readouts from Phase 2 and 3 clinical trials that could lead to FDA filings for expanded indications, including first-line positioning in non-small-cell lung cancer, melanoma, renal cell carcinoma, and hepatocellular carcinoma,” Toung explained.

“We continue to like the company’s long-term prospects and the growth potential of its oncology portfolio,” the analyst added.

Image Credit: By Avarrial (Own work) [CC BY-SA 4.0], via Wikimedia Commons

Latest Ratings for BMY

Date Firm Action From To
Dec 2016 Jefferies Upgrades Hold Buy
Oct 2016 Hilliard Lyons Upgrades Neutral Long-Term Buy
Oct 2016 Credit Suisse Maintains Neutral

View More Analyst Ratings for BMY

View the Latest Analyst Ratings

Posted-In: Analyst Color Biotech Long Ideas News Health Care Reiteration Analyst Ratings Movers Best of Benzinga

Argus Raises Home Depot’s Target To $160 Following Big Q4 Beat

Courtesy of Benzinga.

Argus Raises Home Depot's Target To $160 Following Big Q4 Beat

Argus reiterated its Buy rating and raised its price target on Home Depot Inc (NYSE: HD) by $6 to $160, which implies total return potential of about 13.5 percent including the dividend yield of about 2.5 percent.

The price target change comes after better-than-expected quarterly results from the home improvement retailer. Home Depot reported fourth quarter EPS of $1.44, above the average analyst estimate of $1.33. Comp sales at U.S. stores were up an impressive rate of 6.3 percent, handily topping consensus of 3.5 percent.

Analyst Commentary

Analyst Chris Graja sees continued upside for the shares, despite providing more than double the returns of the S&P 500 over the last two years.

“Increasing returns on capital, signs of improving customer service during recent store visits, rising home prices, and impressive execution of the business plan support our conviction that even after raising the operating margin by more than 450 basis points over the last five years, Home Depot still has room to increase earnings and profitability,” Graja wrote in a note.

Related Link: Large Supplier Checks Have Favorable Read Through For Home Depot, Lowe’s

On the sector front, home prices are only now reaching 2006 peak levels and affordability is still positive. In addition, about two-thirds of U.S. homes are more than 25 years old and likely in need of upgrades and repairs.

Notably, Home Depot has surpassed its financial targets ahead of schedule. It beat its goal of a 13 percent operating margin and a 27 percent ROIC by the end of FY 2016, and set a new goal to raise the operating margin to 14.5 percent and ROIC to 35 percent over the following three years.

“We believe that HD will reach its target for operating margin in the current FY18, which is a year ahead of schedule,” the analyst added.

Shares of Home Depot closed Tuesday’s trading at $145.02.

image Credit: By Tomwsulcer – Own work, CC0,
continue reading



Charlie Munger's Parody

By VW Staff. Originally published at ValueWalk.

Notes from Charlie Munger’s annual meeting at the Daily Journal are making the rounds. This parody, from a few years back, was too good not to share again. “One thing about doing something dumb is that you’re unlikely to do it again.”

]]> Get The Full Series in PDF

Get the entire 10-part series on Charlie Munger in PDF. Save it to your desktop, read it on your tablet, or email to your colleagues.

We respect your email privacy

Charlie Munger's Parody


more from ValueWalk

Phil's Favorites

News You Can Use From Phil's Stock World


Financial Markets and Economy

Oil Slips From 19-Month High as Ample Supply Offsets OPEC Cuts (Bloomberg)

Oil retreated from the highest close since July 2015 in New York as record U.S. crude inventories offset OPEC production curbs.

Sales of New U.S. Homes in January Were Slower Than Forecast (Bloomberg)

Purchases of new U.S. homes in January were slower than forecast, signaling an increase in mortgage rates may be giving some potential buyers pause.


more from Ilene

Market News

News You Can Use From Phil's Stock World


Financial Markets and Economy

Stocks across Europe dived into the weekend (Business Insider)

Stocks all over Europe dived Friday, as markets took a cautious approach and investors took profit after US stocks hit record highs Thursday evening.

Trump Is on the Verge of His Own Bull Market (Bloomberg)

Consecutive gains in the Dow Jones Industrial Average have left it at the doorstep of history, including a 20 percent surge in futures from the early hours of Nov. 9 that could be loosely framed as the president’s own bull market.


more from Paul

Zero Hedge

Size Matters: Visualizing The Tallest Building In Each State

Courtesy of ZeroHedge. View original post here.

The United States has some of the world’s tallest skyscrapers, but their distribution is extremely uneven. Today’s infographic comes from, and it covers the tallest building in each state.

As Visual Capitalist's Jeff Desjardins explains, New York City alone has 6,229 highrises – more than the next nine cities combined, including Chicago, Los Angeles, Honolulu, San Francisco,...

more from Tyler

Digital Currencies

As Bitcoin Surges To Record High, China Prepares Its Own Digital Currency

Courtesy of Mike Shedlock (Mish)

Bitcoin hit an all-time high over $1200 today.

Traders are happy because the SEC is expected to rule on a Bitcoin ETF by March 11.

Meanwhile, Bloomberg reports China Is Developing its Own Digital Currency.

After assembling a research team in 2014, the People’s Bank of China has done trial runs of its prototype cryptocurrency. That’s taking it a step closer to becoming one of the first major central...

more from Bitcoin

Kimble Charting Solutions

Crude Oil; Energy stocks suggesting its about to fall, says Joe Friday

Courtesy of Chris Kimble.

Below takes a look at the price action of Crude Oil, Energy ETF (XLE) and Oil & Gas Exploration ETF (XOP) over the past three years.

Could Energy stocks be suggesting the next big move in Crude Oil again? Which direction are they suggesting?


At this time the intermediate trend in Cru...

more from Kimble C.S.

Chart School

Good Recovery

Courtesy of Declan.

In early morning action it was a clear swing to sellers after yesterday's non-event. However, buyers came back and were able to make a good chunk of these losses into today's close.

Large Caps remained the most attractive as defensive stocks often are during times of doubt. The S&P registered higher volume accumulation as intraday action proved to be relatively tight.

The Nasdaq suffered larger losses, but there was no distribution to go with it. Technicals were relatively immune to today's action.


more from Chart School

Members' Corner

People With Cats Will Understand?

Courtesy of Nattering Naybob

Taking a "potty break" from "in the Toilet Thursday" or "Thursday's in the Loo."

This week's subject is self evident, starring two lovable felines Cole and Marmalade in, People With Cat's Will Understand.


more from Our Members


Swing trading portfolio - week of February 20th, 2017

Reminder: OpTrader is available to chat with Members, comments are found below each post.


This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...

more from OpTrader

Mapping The Market

NSA May Be Withholding Intel from President Trump

By Jean Luc

These GOP guys were so worried about Hillary's email server and now we find out that we had something close to a Russian mole in the White House. In the meantime, Trump keeps on using his unsecured phone, had high level conversation in his resort in front of dinner guests! It's getting so bad that rumors are now circulating that the NSA is not sharing information with the WH:

NSA May Be Withholding Intel from President Trump


….Our spies have had enough of these shady Russian connections—and they are starting to push back….In light of this, and out of worries about the White House’s ability to keep secrets, some of our spy agencies have begun withholding intelligence fro...

more from M.T.M.


Phil's Stock World's Las Vegas Conference!

Learn option strategies and how to be the house and not the gambler. That's especially apropos since we'll be in Vegas....

Join us for the Phil's Stock World's Conference in Las Vegas!

Date:  Sunday, Feb 12, 2017 and Monday Feb 13, 2017            

Beginning Time:  9:30 to 10:00 am Sunday morning

Location: Caesars Palace in Las Vegas


Caesars has offered us rooms for $189 on Saturday night and $129 for Sunday night but rooms are limited at that price.

So, if you are planning on being in Vegas (Highly Recommended!), please sign up as soon as possible by sending...

more from Promotions


The Medicines Company: Insider Buying

Reminder: Pharmboy and Ilene are available to chat with Members, comments are found below each post.

I'm seeing huge insider buying in the biotech company The Medicines Company (MDCO). The price has already moved up around 7%, but these buys are significant, in the millions of dollars range. ~ Ilene




Insider transaction table and buying vs. selling graphic above from

Chart below from


more from Biotech

All About Trends

Mid-Day Update

Reminder: Harlan is available to chat with Members, comments are found below each post.

Click here for the full report.

To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David

FeedTheBull - Top Stock market and Finance Sites

About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>

As Seen On:

About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>